| NONE |
Ares Real Estate Income Trust Inc. |
Roth David A |
Director
|
2026-02-02 |
J - A |
65,343 |
0.00 |
0.00 |
65,343 |
| NONE |
Ares Real Estate Income Trust Inc. |
Holm Andrew Erlich |
Director
|
2026-02-02 |
J - A |
48,750 |
0.00 |
0.00 |
48,750 |
| ANET |
Arista Networks, Inc. |
Giancarlo Charles H |
Director
|
2026-02-02 |
S - D |
1,900 |
138.91 |
263,925.58 |
15,884 |
| ANET |
Arista Networks, Inc. |
Giancarlo Charles H |
Director
|
2026-02-02 |
S - D |
1,590 |
140.27 |
223,036.77 |
14,294 |
| ANET |
Arista Networks, Inc. |
Giancarlo Charles H |
Director
|
2026-02-02 |
S - D |
3,910 |
141.01 |
551,344.02 |
10,384 |
| ANET |
Arista Networks, Inc. |
Giancarlo Charles H |
Director
|
2026-02-02 |
S - D |
600 |
141.94 |
85,162.38 |
9,784 |
| OFG |
OFG BANCORP |
Arizmendi Maritza |
Officer
|
2026-02-02 |
A - A |
7,650 |
0.00 |
0.00 |
66,120 |
| OFG |
OFG BANCORP |
Arizmendi Maritza |
Officer
|
2026-02-02 |
F - D |
2,508 |
41.26 |
103,480.08 |
63,612 |
| AVBP |
ArriVent BioPharma, Inc. |
Kastenmayer James Paul |
Officer
|
2026-02-02 |
A - A |
130,000 |
0.00 |
0.00 |
130,000 |
| AVBP |
ArriVent BioPharma, Inc. |
Yao Zhengbin |
Director
Officer
|
2026-02-02 |
A - A |
550,000 |
0.00 |
0.00 |
550,000 |
| AVBP |
ArriVent BioPharma, Inc. |
Kung Winston |
Officer
|
2026-02-02 |
A - A |
140,000 |
0.00 |
0.00 |
140,000 |
| AVBP |
ArriVent BioPharma, Inc. |
Lutzker Stuart |
Director
Officer
|
2026-02-02 |
A - A |
150,000 |
0.00 |
0.00 |
150,000 |
| AVBP |
ArriVent BioPharma, Inc. |
LaChapelle Robin |
Officer
|
2026-02-02 |
A - A |
130,000 |
0.00 |
0.00 |
130,000 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
18,553,846 |
1.30 |
24,119,999.80 |
154,734,327 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
3,846,154 |
1.30 |
5,000,000.20 |
7,362,368 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
P - A |
1,538,462 |
1.30 |
2,000,000.60 |
1,538,462 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
367,145 |
65.00 |
23,864,432.80 |
367,145 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
18,553,846 |
1.30 |
24,119,999.80 |
154,734,327 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
3,846,154 |
1.30 |
5,000,000.20 |
7,362,368 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
P - A |
1,538,462 |
1.30 |
2,000,000.60 |
1,538,462 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
367,145 |
65.00 |
23,864,432.80 |
367,145 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
18,553,846 |
1.30 |
24,119,999.80 |
154,734,327 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
3,846,154 |
1.30 |
5,000,000.20 |
7,362,368 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
P - A |
1,538,462 |
1.30 |
2,000,000.60 |
1,538,462 |
| LXRX |
LEXICON PHARMACEUTICALS, INC. |
Stichting Administratiekantoor Westend |
|
2026-02-02 |
A - A |
367,145 |
65.00 |
23,864,432.80 |
367,145 |